1[2]Ihara M,Urata H,Kinoshita A,et al.Increased chymase-Dependent angiotensin Ⅱ formation in human atherosclerotic aorta.Hypertension,1999,33:1399-1405.
2[3]Guo CY,Ju HS,Debbie L,et al.A novel vascular smooth muscle chymase is upregulated in hypertensive rats.J Clin Invest,2001,107:703-715.
3[4]Saris JJ,van Dijk MA,Kroon I,et al.Functional importance of angiotensin-converting enzyme-dependent in situ angiotensin Ⅱ generation in the human forearm.Hypertension,2000,35:764 -768.
4[5]Burrell LM,Johnston CI,Tikellis C,et al.ACE2,a new regulator of the renin-angiotensin system.Trends Endocrinol Metab,2004,15:166-169.
5[6]Carlos M,Aaron J,Jewell A.Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function.Am J Physiol Heart Circ Physiol,2005,289:H2281-H2290.
6[7]Yagil Y,Yagil C.Hypothesis:ACE2 modulates blood pressure in the mammalian organism.Hypertension,2003,41:871-873.
7[8]Tom B,Dendorfer A,Danser AH.Bradykinin,angiotensin-(1-7),and ACE inhibitors:how do they interact? Int J Biochem Cell Biol,2003,35:792-801.
8[9]Ferrario CM,Jessup J,Chappell MC,et al.Effect of angiotensinconverting enzyme inhibition and angiotensin Ⅱ receptor blockers on cardiac angiotensin -converting enzyme 2.Circulation,2005,111:2605-2610.
9[10]Campbell DJ,Krum H,Esler MD.Losartan increases bradykinin levels in hypertensive humans.Circulation,2005,111:315-320.
